| Reader, I was excited when I read about a highly effective herbal remedy that slashes your risk of developing type 2 diabetes.
And while it's available in Europe, Asia, and many other countries around the world, it could be years before you can get your hands on it.
I'm talking about a traditional herbal formula called Jinlida.
But the mountain of American regulatory hurdles – as well as the expected opposition from Big Pharma – means you may never be able to access it.
More on this in a moment…
Big Pharma makes enormous profits on diabetes drugs like alpha-glucosidase inhibitors, which help lower blood sugar levels, and biguanides that decrease the amount of glucose your liver makes.
You might know these drugs by names like Precose, Metformin Hcl, and Riomet.
The global market for type 2 diabetes medications is already worth around $30 billion and is expected to increase to more than $62 billion over the next few years.
And with the incidence of the diabetes epidemic predicted to surge… it's hardly surprising that Big Pharma and their cronies in the FDA would resist the approval of Jinlida.
But multiple studies prove that Jinlida works.
In a recent study, published in JAMA Internal Medicine, the treatment was tested over a two-year period on 885 participants, aged 18 to 70. The participants had impaired glucose tolerance and elevated blood sugar levels, but had not yet reached the threshold for a diabetes diagnosis.1
Half the participants received a placebo, and the other half took Jinlida granules.
The results for those taking Jinlida were spectacular.
Those who received the herbal formula slashed the risk of developing full-blown diabetes by a staggering 41%.
They also reduced abdominal fat and ended up with healthier cholesterol levels.
At the same time, researchers noted significant decreases in both after-meal and fasting blood sugar levels, as well as a lower HbA1c, a measure of long-term blood glucose control.
This latest study backs up the findings of previous Jinlida studies.2,3 Slash Your Diabetes Risk Today While you may have to wait years for Jinlida to win FDA approval, the good news is that its three main active ingredients are already available.4 - Ingredient #1 – Quercetin: This common antioxidant and anti-inflammatory has long been known for its antidiabetic effects. Several studies reveal that quercetin can regulate key signalling pathways involved in glucose metabolism. It has been shown to reduce oxidative stress and improve insulin resistance.5
Good sources of quercetin are onions, citrus fruits, berries, red grapes, tomatoes, apples, broccoli, capers, and cherries.
But it's almost impossible to get what you need from food. I recommend supplementing with 500 mg twice a day.
- Ingredient #2 – Luteolin: I've been recommending this cancer preventive to my patients for years. Now, studies show it can also have a significant impact in the management of diabetes.6
In one study, luteolin was confirmed to dramatically reduce mortality rates among type 2 diabetics, largely thanks to its powerful anti-inflammatory properties.7
Luteolin is found in many foods, including celery, green peppers, thyme, and chamomile tea.
If you choose to supplement, I suggest taking 100 mg daily.
- Ingredient #3 – Baicalein: This is another plant antioxidant with powerful blood-sugar lowering and immune system-boosting properties.
Baicalein – also known as Chinese skullcap – has been used for centuries to treat high blood pressure, hepatitis, acute gastroenteritis, and acute respiratory infections.
Multiple studies have proven its effectiveness against type 2 diabetes, largely by working to reverse insulin resistance and regulating glucose metabolism in the liver.8,9
I recommend 500 mg of baicalein (Scutellaria baicalensis) twice a day. But when purchasing, be careful not to confuse it with American skullcap (Scutellaria lateriflora), which is a different plant.
Chinese skullcap should also be avoided by children and pregnant or breastfeeding mothers.
To Your Good Health, 
Al Sears, MD, CNS
References: - Ji H, et al. "Jinlida for diabetes prevention in impaired glucose tolerance and multiple metabolic abnormalities: The FOCUS Randomized clinical trial." JAMA Intern Med. 2024;184(7):727–735.
- Kang X, et al. "Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial." Front Endocrinol. Sec Clinical Diabetes. 2023;14.
- Pan J, et al. "The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial. J Diabetes Res. 2021; Oct 8;2021:6303063.
- Gu H, et al. "Exploring the mechanism of Jinlida granules against type 2 diabetes mellitus by an integrative pharmacology strategy." Sci Rep 14, 10286. 2024.
- Dhanya R. "Quercetin for managing type 2 diabetes and its complications, an insight into multitarget therapy." Biomed Pharmacother. Vol 146. 2022.
- Pradhan G, Kulkarni YA. "Diabetes and its Complications: Role of Luteolin, A Wonder Chemical from the Natural Source." Curr Diabetes Rev. 2024.
- Zhang W, et al. "Luteolin intake is negatively associated with all-cause and cardiac mortality among patients with type 2 diabetes mellitus." Diabetol Metab Syndr 15, 59. 2023.
- Szkudelski T, Szkudelska K. "The Anti-Diabetic Potential of Baicalin: Evidence from Rodent Studies." Int J Mol Sci. 2023 Dec 28;25(1):431.
- Zhao W, et al. "Unveiling Anti-Diabetic Potential of Baicalin and Baicalein from Baikal Skullcap: LC–MS, In Silico, and In Vitro Studies." International Journal of Molecular Sciences. 2024; 25(7):3654.
|
No comments:
Post a Comment